Back
Sorrento Therapeutics Quote, Financials, Valuation and Earnings
Sell
41
SRNE
Sorrento Therapeutics
Last Price:
0.0100
Seasonality Move:
80.25%
7 Day Trial
ALL ACCESS PASS
$
7
Sorrento Therapeutics Price Quote
$0.0100
-0.0030 (-23.08%)
(Updated: May 16, 2024 at 6:55 PM ET)
Sorrento Therapeutics Key Stats
Sell
41
Sorrento Therapeutics (SRNE)
is a Sell
Day range:
$0.0002 - $0.0135
52-week range:
$0.0001 - $0.4190
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
122.5K
Avg. volume:
212.7K
1-year change:
-94.58%
Market cap:
$7.2M
Revenue:
$62.8M
EPS:
$-1.12
How Much Does Sorrento Therapeutics Make?
-
How Much Are Sorrento Therapeutics's Sales Annually?
SRNE Revenues are $62.8M -
How Much Profit Does Sorrento Therapeutics's Make A Year?
SRNE net income is -$572.8M
Is Sorrento Therapeutics Growing As A Company?
-
What Is Sorrento Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.31% -
What Is Sorrento Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sorrento Therapeutics Stock Price Performance
-
Did Sorrento Therapeutics Stock Go Up Last Month?
Sorrento Therapeutics share price went down by -60.61% last month -
Did SRNE's Share Price Rise Over The Last Year?
SRNE share price fell by -94.58% over the past 1 year
What Is Sorrento Therapeutics 52-Week High & Low?
-
What Is Sorrento Therapeutics’s 52-Week High Share Price?
Sorrento Therapeutics has traded as high as $0.4190 over the past 52 weeks -
What Is Sorrento Therapeutics’s 52-Week Low Share Price?
Sorrento Therapeutics has traded as low as $0.0001 over the past 52 weeks
Sorrento Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sorrento Therapeutics?
-
How Much Debt Does Sorrento Therapeutics Have?
Total long term debt quarterly is $142.1M -
How Much Cash Does Sorrento Therapeutics Have?
Cash and short term investments quarterly total is $80.6M -
What Is Sorrento Therapeutics’s Book Value Per Share?
Book value per share is -0.37
Is Sorrento Therapeutics Cash Flow Positive?
-
What Is SRNE Cash Flow From Operations?
Cash flow from operations (TTM) is -$234.6M -
What Is Sorrento Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $246.6M -
What Is Sorrento Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$11.6M
Sorrento Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SRNE return on invested capital is -794.42% -
What Is Sorrento Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -103.91% -
What Is SRNE Return On Equity?
ROE is a measure of profitability and is 0%
Sorrento Therapeutics Earnings Date & Stock Price
-
What Is Sorrento Therapeutics's Stock Price Today?
A single share of SRNE can be purchased today for 0.0130 -
What Is Sorrento Therapeutics’s Stock Symbol?
Sorrento Therapeutics trades on the otcm under the ticker symbol: SRNE -
When Is Sorrento Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sorrento Therapeutics is scheduled on May 31, 2024 -
When Is SRNE's next ex-dividend date?
Sorrento Therapeutics's next ex-dividend date is May 17, 2024 -
How To Buy Sorrento Therapeutics Stock?
You can buy Sorrento Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sorrento Therapeutics Competitors
-
Who Are Sorrento Therapeutics's Competitors?
Below is a list of companies who compete with Sorrento Therapeutics or are related in some way:
Sorrento Therapeutics Dividend Yield
Data Unavailable
Sorrento Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 31.1% | -18.75% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 13.0000 |
| Upside from Last Price: | 99900% |